Clinical Trial Update: Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab combined with celecoxib and regorafenib for refractory advanced colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Celecoxib (Celecoxib)
• Regorafenib (regorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: UNKNOWN